
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is well-positioned for future growth with its strong partnerships with top-tier insurers like Centene and its focus on self-funding arrangements with employers. Additionally, the company's exit from the Exchange business will allow it to focus on core growth opportunities and its emphasis on high-growth areas of commercial membership with deeper integration into its subsidiary Evernorth's services will further drive growth. With strong financials, a diverse and experienced leadership team, and a commitment to sustainability, we see continued success for Cigna Group in the future.
Bears say
Cigna Group is facing execution risks in accurately managing healthcare costs, potential margin erosion in Evernorth due to transitions to a rebate-free model, and potential impacts from biosimilar adoption and client losses for Evernorth. Additionally, a rise in unemployment and economic downturn could affect its commercial membership growth. However, as a global managed care organization, Cigna is focused on improving access and affordability of healthcare, and its diverse products and services make it an attractive investment for sustainability-oriented investors. Despite potential risks, its recent multiyear deals and positive financial guidance show a strong outlook for Cigna's financial performance, making it an attractive name to own with a revised price target of $340.00 in the next 12 months.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares